PMC:7291971 / 2487-2628 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T51","span":{"begin":60,"end":70},"obj":"SP_7"},{"id":"T52","span":{"begin":115,"end":122},"obj":"NCBITaxon:10239"}],"text":"V, case fatality rate ≈ 36% [3]) and in late december 2019 (SARS-CoV-2) [4] illustrate the critical impact of such viruses. The ongoing COVID"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T11","span":{"begin":60,"end":68},"obj":"Disease"}],"attributes":[{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"V, case fatality rate ≈ 36% [3]) and in late december 2019 (SARS-CoV-2) [4] illustrate the critical impact of such viruses. The ongoing COVID"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T15","span":{"begin":24,"end":26},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"},{"id":"T16","span":{"begin":115,"end":122},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"V, case fatality rate ≈ 36% [3]) and in late december 2019 (SARS-CoV-2) [4] illustrate the critical impact of such viruses. The ongoing COVID"}

    2_test

    {"project":"2_test","denotations":[{"id":"32563813-27344959-29105562","span":{"begin":29,"end":30},"obj":"27344959"},{"id":"32563813-32015508-29105563","span":{"begin":73,"end":74},"obj":"32015508"}],"text":"V, case fatality rate ≈ 36% [3]) and in late december 2019 (SARS-CoV-2) [4] illustrate the critical impact of such viruses. The ongoing COVID"}

    MyTest

    {"project":"MyTest","denotations":[{"id":"32563813-27344959-29105562","span":{"begin":29,"end":30},"obj":"27344959"},{"id":"32563813-32015508-29105563","span":{"begin":73,"end":74},"obj":"32015508"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"V, case fatality rate ≈ 36% [3]) and in late december 2019 (SARS-CoV-2) [4] illustrate the critical impact of such viruses. The ongoing COVID"}